U.S. stocks rally widens as falling oil prices and lower Treasury yields boost sectors beyond technology, lifting healthcare ...

Nordica's Fibroid Care Centre has treated 1,000 women with fibroids and adenomyosis using a non-surgical technology called High-Intensity Focused Ultrasoun ...

Thousands of biting Asian ladybirds are swarming across the UK as the weather turns colder, with some homeowners finding their properties covered in the invasive insects. The non-native harlequin ...

Discover how MahaVastu's Industrial Vastu protocol revolutionizes factory productivity. This spatial management framework ...

WT outcomes have improved substantially through progress in molecular diagnosis, chemotherapy, radiotherapy, and surgery. Yet ...

Surgery should remain the primary treatment for people with early-stage non-small cell lung cancer (NSCLC) who are suitable ...

INOVIO (NASDAQ: INO) leads Nasdaq gainers, up 213.75%, after the FDA granted accelerated approval for VOCERYQ (INO-3107) for ...

Lyme-Old Lyme High School students plant native shrubs, tend local trails and harvest sweet potatoes through the ECOS Club’s environmental stewardship efforts.

FDA grants accelerated approval to INOVIO’s Voceryq for reducing surgery frequency in adults with recurrent respiratory ...

Poster #2034: Ex vivo blood assays demonstrate systemic anti-inflammatory activity of G1090N, a novel formulation of nitazoxanide, and support further clinical evaluation in acute-on-chronic liver ...

UroGen Pharma stock falls 2.2% to $32.72 today. The first patient begins treatment in a Phase 1 study of UGN-501.

Ractigen Therapeutics, a leading clinical-stage biopharmaceutical company developing innovative small activating RNA (saRNA) ...